Probiotics to prevent gastrointestinal toxicity from cancer therapy: An interpretive review and call to action

Current Opinion in Supportive and Palliative Care

Volumn 9, Issue 2, 2015, Pages 157-162

  Ciorba, Matthew A ^a   Hallemeier, Christopher L ^b   Stenson, William F ^a   Parikh, Parag J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

diarrhea; fluorouracil; metabolome; microbiota; prebiotic; probiotics

Indexed keywords

ANTINEOPLASTIC AGENT; PROBIOTIC AGENT;

ABDOMINAL NEOPLASMS; ADVERSE EFFECTS; CLINICAL TRIAL (TOPIC); COMPLICATION; DRUG EFFECTS; ENTERITIS; HUMAN; IMMUNOLOGY; LACTOBACILLUS; MICROBIOLOGY; MICROFLORA; MUCOSITIS; PATHOPHYSIOLOGY; PELVIC NEOPLASMS; PHYSIOLOGY; RADIATION RESPONSE;

ABDOMINAL NEOPLASMS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; ENTERITIS; HUMANS; LACTOBACILLUS; MICROBIOTA; MUCOSITIS; PELVIC NEOPLASMS; PROBIOTICS; RADIOTHERAPY;

EID: 84946165965     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0000000000000134     Document Type: Review

References (27)

1. Hauer-Jensen M, Denham JW, Andreyev HJ. Radiation enteropathy-pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol 2014; 11:470-479.
2. Packey CD, Ciorba MA. Microbial influences on the small intestinal response to radiation injury. Curr Opin Gastroenterol 2010; 26:88-94.
3. Touchefeu Y, Montassier E, Nieman K, et al. Systematic review: the role of the gut microbiota in chemotherapy-or radiation-induced gastrointestinal mucositis: current evidence and potential clinical applications. Aliment Pharmacol Ther 2014; 40:409-421.
4. Ciorba MA, Stenson WF. Probiotic therapy in radiation-induced intestinal injury and repair. Ann N Y Acad Sci 2009; 1165:190-194.
5. Lalla RV, Bowen J, Barasch A, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 2014; 120:1453-1461.
6. Gibson RJ, Keefe DM, Lalla RV, et al. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 2013; 21:313-326.
7. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004; 4:277-284.
8. Crawford PA, Gordon JI. Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci USA 2005; 102:13254-13259.
9. McLaughlin MM, Dacquisto MP, Jacobus DP, Horowitz RE. Effects of the germfree state on responses of mice to whole-body irradiation. Radiat Res 1964; 23:333-349.
10. Burdelya LG, Krivokrysenko VI, Tallant TC, et al. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 2008; 320:226-230.
11. Riehl T, Cohn S, Tessner T, et al. Lipopolysaccharide is radioprotective in the mouse intestine through a prostaglandin-mediated mechanism. Gastroenterology 2000; 118:1106-1116.
12. Ciorba MA, Riehl TE, Rao MS, et al. Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gut 2012; 61:829-838.
13. Manichanh C, Varela E, Martinez C, et al. The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol 2008; 103:1754-1761.
14. Stringer AM, Al-Dasooqi N, Bowen JM, et al. Biomarkers of chemotherapyinduced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases. Support Care Cancer 2013; 21:1843-1852.
15. Lin PW, Myers LE, Ray L, et al. Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med 2009; 47:1205-1211.
16. Ciorba MA. A gastroenterologist's guide to probiotics. Clin Gastroenterol Hepatol 2012; 10:960-968.
17. Salminen E, Elomaa I, Minkkinen J, et al. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 1988; 39:435-437.
18. Delia P, Sansotta G, Donato V, et al. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 2007; 13:912-915.
19. Delia P, Sansotta G, Donato V, et al. Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation. Am J Gastroenterol 2002; 97:2150-2152.
20. Giralt J, Regadera JP, Verges R, et al. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys 2008; 71:1213-1219.
21. Chitapanarux I, Chitapanarux T, Traisathit P, et al. Randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol 2010; 5:31.
22. Osterlund P, Ruotsalainen T, Korpela R, et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer 2007; 97:1028-1034.
23. Fuccio L, Guido A, Eusebi LH, et al. Effects of probiotics for the prevention and treatment of radiation-induced diarrhea. J Clin Gastroenterol 2009; 43:506-513.
24. Demers M, Dagnault A, Desjardins J. A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation. Clin Nutr 2014; 33:761-767.
25. Urbancsek H, Kazar T, Mezes I, Neumann K. Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol 2001; 13:391-396.
26. Nascimento M, Aguilar-Nascimento JE, Caporossi C, et al. Efficacy of synbiotics to reduce acute radiation proctitis symptoms and improve quality of life: a randomized, double-blind, placebo-controlled pilot trial. Int J Radiat Oncol Biol Phys 2014; 90:289-295.
27. Gibson RJ. The urgent need for an effective biomarker for cytotoxic therapy-induced adverse effects. Curr Opin Support Palliat Care 2013; 7:153-154.